Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.855
+0.105 (6.00%)
Jan 22, 2026, 2:37 PM EST - Market open

Palisade Bio Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
276.40M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023250.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 201915.39K-244.61K-94.08%
Dec 31, 2018260.00K--
Dec 31, 2017260.00K243.75K1,500.39%
Dec 31, 201616.25K5.83K55.96%
Dec 31, 201510.42K-8.42K-44.69%
Dec 31, 201418.83K-91.17K-82.88%
Dec 31, 2013110.00K-297.71K-73.02%
Dec 31, 2012407.71K17.08K4.37%
Dec 31, 2011390.63K-342.81K-46.74%
Dec 31, 2010733.44K--
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007306.06K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics155.10M
Fennec Pharmaceuticals38.79M
Silence Therapeutics25.83M
Shattuck Labs1.00M
Neurogene925.00K
Revenue Rankings